Current State of Stroke Care in the Philippines

Abstract

Stroke remains the leading cause of disability and death in the Philippines. Evaluating the current state of stroke care, the needed resources, and the gaps in health policies and programs is crucial to decrease stroke-related mortality and morbidity effectively. This paper aims to characterize the Philippines' stroke system of care and network using the World Health Organization health system building blocks framework. To integrate existing national laws and policies governing stroke and its risk factors dispersed across many general policies, the Philippine Department of Health (DOH) institutionalized a national policy framework for preventing and managing stroke. Despite policy reforms, government financing coverage remains limited. In terms of access to medicines, the government launched its stroke medicine access program (MAP) in 2016, providing more than 1,000 vials of recombinant tissue plasminogen activator (rTPA) or alteplase subsidized to selected government hospitals across the country. However, DOH discontinued the program due to the lack of neuroimaging machines and organized system of care to support the provision of the said medicine. Despite limited resources, stroke diagnostics and treatment facilities are more concentrated in urban settings, mostly in private hospitals, where out-of-pocket expenditures prevail. These barriers to access are also reflective of the current state of human resource on stroke where medical specialists (e.g., neurologists) serve in the few tertiary and training hospitals situated in urban settings. Meanwhile, there is no established unified national stroke registry thus, determining the local burden of stroke remains a challenge. The lack of centralization and fragmentation of the stroke cases reporting system leads to reliance on data from hospital records or community-based stroke surveys, which may inaccurately depict the country's actual stroke incidence and prevalence. Based on these gaps, specific recommendations geared toward systems approach - governance, financing, information system, human resources for health, and medicines were identified.

Autoimmune Encephalitis in the Philippines: A Scoping Review on the Treatment Gaps, Challenges, and Current State of Care

“…This inadequate coverage of government-led health care financing led the majority of Filipinos to spend from their own pockets. These findings are in line with the recent studies addressing the gaps in the management of different neurologic diseases (Parkinson's disease, primary brain tumor, multiple sclerosis, epilepsy, stroke) in the Philippines (23,33,(42)(43)(44).…”

“…While their value has not been fully investigated, the outcomes of rehabilitation from clinical experiences are promising (5). There are 452 rehabilitation centers and 316 rehabilitation medicine specialists in the country (42). However, the distribution of rehabilitation centers and rehabilitation medicine specialists is also skewed toward the urban areas (43).…”

Stroke systems of care in the Philippines: Addressing gaps and developing strategies

“…About 50% of the population do not have access to primary care facilities within 30 min ( 6 ). Uncontrolled risk factors, poor stroke awareness, delay of hospital access, high out-of-pocket medical expenses, overcrowding of public hospitals, inadequate CT scan machines and lack of stroke training among health workers could have contributed to the high stroke mortality rate ( 7 ).…”

Clinical Profile of Cerebrovascular Disease Population in Sorsogon: A Hospital-based Study

“…2,11 This is also the case in the Philippines, wherein three out of 10 cases of diagnosed stroke are the hemorrhagic type of stroke. 12 With a global advancement in healthcare, life expectancies have also increased. 6 The local data available is a community-based survey that stated that the national prevalence of stroke is 486 per 100,000 of the population and 1,400 per 100,000 in those aged ≥40 years.…”

“…Most patients seek medical consultation beyond the time window of the standard of care (i.e., intravenous thrombolysis or endovascular therapy) for stroke. 12 Patients, upon evaluation, undergo diagnostic procedures and are given appropriate treatments to the extent they can shoulder out of pocket.…”